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Painful peripheral neuropathy often occurs without apparent un-
derlying cause. Gain-of-function variants of sodium channel Nav1.7
have recently been found in ∼30% of cases of idiopathic painful
small-fiber neuropathy. Here, we describe mutations in Nav1.8,
another sodium channel that is specifically expressed in dorsal root
ganglion (DRG) neurons and peripheral nerve axons, in patients
with painful neuropathy. Seven Nav1.8 mutations were identified
in 9 subjects within a series of 104 patients with painful predom-
inantly small-fiber neuropathy. Three mutations met criteria for
potential pathogenicity based on predictive algorithms and were
assessed by voltage and current clamp. Functional profiling
showed that two of these three Nav1.8 mutations enhance the
channel’s response to depolarization and produce hyperexcitabil-
ity in DRG neurons. These observations suggest that mutations of
Nav1.8 contribute to painful peripheral neuropathy.
dorsal root ganglia | patch clamp
Painful peripheral neuropathy involving small-diameter noci-ceptive nerve fibers represents a significant public health chal-
lenge (1); in about one-half of cases, no cause can be identified
(1). Faber et al. (2) recently described gain-of-function variants
(single amino acid substitutions) in sodium channel Nav1.7, which
is abundantly expressed in spinal sensory [dorsal root ganglion
(DRG)] neurons and their axons (3) in nearly 30% of patients
with biopsy-confirmed, painful small-fiber neuropathy (SFN) and
no other apparent cause. These variants increase the excitability of
DRG neurons, providing an explanation for pain in these patients.
Molecular substrates for pain in the remaining SFN patients re-
main unknown. Here, we describe gain-of-function mutations
in Nav1.8, another sodium channel that is specifically expressed
in DRG neurons and peripheral nerve axons, in human subjects
with painful neuropathy, including a father–son pair. These muta-
tions alter gating properties of the channel in a proexcitatory
manner and increase the excitability of DRG neurons. These
genetic and functional observations suggest that Nav1.8 muta-
tions contribute to pain in some peripheral neuropathies.
Results
Genomic analysis of SCN10A was performed in 104 patients with
idiopathic painful predominantly SFN, all negative for mutations
in SCN9A. All patients underwent clinical, nerve conduction, and
skin biopsy assessment. Among them, we identified nine patients
carrying seven variants in SCN10A. Here, we describe two gain-
of-function mutations in SCN10A, which we identified in three
patients with painful neuropathy.
Clinical Description. Patient 1, a 67-y-old man with unremarkable
medical history, complained of burning and intense paroxysmal
itch in the feet that interfered with sleep for more than 10 y
Neurological examination and nerve conduction studies were
normal [sural sensory nerve action potential amplitude, 11 μV
(normal >6); conduction velocity (CV), 43 m/s (>40); compound
muscle action potential peroneal nerve, 5.4 mV (>4); CV, 46.3 m/s
(>42)]. Skin biopsy showed reduced intraepidermal nerve fiber
(IENF) density in the distal leg (2.0 IENF/mm; fifth percentile,
2.8 IENF/mm for age and sex; median per age span, 8.3 IENF/mm)
(4), confirming the diagnosis of SFN. Thorough screening excluded
any underlying systemic causes and ruled out diabetes and im-
paired glucose intolerance.
Patient 2, the son of case 1, developed intense paroxysmal
burning pain (scored 8 on a visual analog scale) in the feet and
legs at age 39 y, with severe allodynia and hyperalgesia. Diagnosis
of predominantly SFN was confirmed by skin biopsy showing
complete epidermal denervation (0 IENF/mm; fifth percentile, 4.4
IENF/mm for age and sex; median per age span, 9.6 IENF/mm)
(4) (Fig. 1). The patient had >20-y type I diabetes with well-
controlled glucose and HBA1c levels. In addition to debilitating
SFN, signs of large-fiber involvement were also found at exami-
nation. Sural nerve action potential amplitude (2 μV; normal, >10
μV), CV (39 m/s; normal, >42 m/s), and peroneal compound
motor action potential amplitude (2.1 mV; normal, >4 mV)
were reduced.
Patient 3 is a 69-y-old woman with stabbing pain in her feet,
lower legs, and hands, and intolerance to sheets over her feet for
4 y. Warmth gave some relief. Her soles occasionally showed red
discoloration. Family history was unremarkable. Nerve conduc-
tion studies showed normal sural distal motor latency and CV
(distal motor latency, 2.20 ms; amplitude, 5.6 μV; CV, 55 m/s).
Quantitative sensory testing showed abnormal thresholds for
warmth and cold sensation in both feet (5, 6). Skin biopsy
showed IENF density of 5.3 per mm, which is normal compared
with normative values (fifth percentile cutoff, 3.2 per mm; me-
dian per age span, 8.7 IENF/mm) (4).
DNA Analysis. Nine patients, including a father–son pair, carried
seven missense variants in SCN10A gene encoding for Nav1.8.
Substitutions in SCN10A were selected for voltage- and current-
clamp assessment, after expression in DRG neurons based on
the following criteria: (i) substitution either previously unreported
or reported at allelic frequency of <1% in public databases (The
1000 Genomes Project, dbSNP, Exome database) and in a control
population; (ii) familial substitutions, when present, segregate
in affected individuals; (iii) substitutions that alter conserved
residues in transmembrane segments, or in previously identified
functional motifs that regulate Nav1.8 current density or gating.
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Of the seven variants identified [c.1661T > C (p.Leu554Pro) (n =
2); c.2816C > T (p.Pro939Leu); c.2819A > T (p.Gln940Leu);
c.3166G > A (p.Asp1056Asn); c.3910G > A (p.Ala1304Thr);
c.4568G >A (p.Cys1523Tyr) (n = 2); c.4984G >A (p.Gly1662Ser)],
three fulfilled selection criteria for functional testing: c.1661T >
C (p.Leu554Pro), c.3910G > A (p.Ala1304Thr), and c.4568G >
A (p.Cys1523Tyr). The first two mutations demonstrated gain-
of-function in SCN10A and are described in this paper.
A previously unreported missense mutation (c.1661T > C;
p.Leu554Pro) in exon 11 of SCN10A gene, found in patients 1 and
2 (both heterozygous), was not found in 325 healthy blood donors
(650 chromosomes) from the same geographical region as the
index patient. This substitution has been reported in dbSNP
(rs138404783) with a frequency of <0.001 (once in 4,552 chro-
mosomes). The mutation substitutes leucine 554 by proline within
a proline-rich motif, which is highly conserved in loop 1 (L1)
among Nav1.8 mammalian orthologs.
Mutation c.3910G > A (p.Ala1304Thr) found in patient 3, was
not found in 600 controls (100 from ethically matched Dutch;
500 from the twin research KCL) and has not been reported in
the literature, nor in dbSNP, The 1000 Genomes Project, and
Exome Variant Server. The variant substitutes alanine 1304 by
threonine, likely resulting in alteration of polarity. Alanine 1304 is
highly conserved in multiple species and in other SCN proteins,
and is located in transmembrane domain DIII/S5.
Electrophysiology. Nav1.8 is resistant to block by TTX (TTX-R)
and displays depolarized voltage dependence of activation and
fast inactivation. Nav1.8 is the major contributor to the action
potential upstroke during repetitive firing in DRG neurons (7, 8).
L554P. To determine whether the L554P and A1304T mutations
alter biophysical properties of Nav1.8, constructs encoding WT,
L554P and A1304T channels were transiently transfected into
homozygous Nav1.8-cre DRG neurons (lacking endogenous
Nav1.8) in sister cultures prepared in parallel. In 1 μM TTX,
large voltage-dependent, slowly inactivating inward currents were
recorded from DRG neurons transfected with WT or mutant
channels (Fig. 2A), indicating expression of functional channels
at current densities that were not significantly different (WT: 261 ±
35 pA/pF, n = 38; L554P: 257 ± 33 pA/pF, n = 40; P > 0.05).
WT and L554P channels produced large persistent currents
(WT: 10.7 ± 0.7% of peak transient current, n = 19; L554P: 12.4 ±
0.5%, n = 14; P > 0.05), probably due to slow inactivation. The
half-voltage for activation (V1/2,act) and fast inactivation (V1/2,fast)
of WT channels (Table 1) were consistent with the previously
reported depolarized voltage dependence of Nav1.8 (9–11).
L554P had no significant effect on activation or steady-state fast
inactivation (Fig. 2B, Table 1), or slow inactivation (Table 1).
L554P increased recovery from fast inactivation (repriming) at
−50 mV (Fig. 2C), close to resting potential.
The response to slow ramp stimuli (−80 to +40 mV over 600
ms) was one-third larger at peak for L554P compared with WT
channels (Fig. 2D) (WT: 22.3 ± 1.6%, n = 25; L554P: 28.9 ±
2.2%, n = 23; P < 0.05). The potential of peak ramp current
(VRamp) was −19.1 ± 1.3 mV (n = 25) for WT and −19.3 ± 1.4 mV
(n = 23) for L554P. The ramp response of Nav1.8 is ∼20 times
Fig. 1. Loss of IENFs. Immunohistochemical studies (polyclonal anti-protein
gene product 9.5 antibody) in sections of skin biopsy at distal leg in a father–
son pair (A and B), both harboring L554P mutation in Nav1.8, and in healthy
subject (C). Arrows indicate IENF; arrowheads indicate dermal nerve bundles.
Patient 2 (A) showed complete depletion of IENFs and severe reduction in
density of dermal nerve bundles, which appeared fragmented due to axonal
degeneration. Patient 1 (B) showed almost complete loss of IENFs. Inset
shows IENF (white arrow) branching after penetrating the epidermis, with
large swelling (bent arrow) representing typical axonal predegeneration
state. A and B are typical of SFN. For comparison, C shows diffuse in-
nervation of epidermis and dermis in a healthy subject. (Scale bar, 50 μm.)
Fig. 2. L554P mutation alters hNav1.8 channel properties. (A) Representa-
tive hNav1.8 WT (black) and L554P (red) currents recorded from DRG neu-
rons. (B) Activation and steady-state fast inactivation were not significantly
different. (C ) L554P displays enhanced recovery from fast inactivation at
−50 mV, close to resting membrane potential of DRG neurons, compared
with WT channel (P < 0.05). Data are presented as means ± SEM. (D) Aver-
aged ramp currents (normalized to maximal transient peak current) pro-
duced by WT Nav1.8 (black; n = 25) and L554P (red; n = 23) channels. SEM is
indicated by error bars every 2 mV. Mean normalized amplitude of peak ramp
currents are significantly larger for L554P (WT: 22.3 ± 1.6%, n = 25; L554P:
28.9 ± 2.2%, n = 23; P < 0.05).








larger than that of Nav1.7, and the enhanced ramp response of
L554P is predicted (12, 13) to increase excitability in DRG neurons.
To assess the effect of the L554P mutation on excitability, we
expressed WT and L554P channels in small DRG neurons (<30
μm diameter) and performed current-clamp recordings (Fig.
3). Input resistance was not significantly different in DRG neu-
rons expressing WT (669 ± 84 MΩ; n = 33) or L554P mutant
channels (696 ± 90 MΩ; n = 29). Resting potential was not sig-
nificantly different in DRG neurons expressing WT (−50.1 ± 1.3
mV; n = 33) or L554P mutant channels (−49.6 ± 1.4 mV; n = 29).
Current threshold was significantly reduced after expression of
L554P (80 ± 14 pA; n = 29), compared with WT channels (141 ±
20 pA; n = 33; P < 0.05) (Fig. 3D). Voltage threshold (the
voltage at which action potential take-off occurs) of DRG neu-
rons expressing L554P (−26.3 ± 1.0 mV; n = 29) or WT channels
(−24.7 ± 0.9 mV; n = 33) was not significantly different. There
was no significant difference in action potential amplitude (WT:
105.5 ± 1.9 mV, n = 33; L554P: 104.5 ± 2.0 mV, n = 29), or half-
width (WT: 7.82 ± 0.63 ms, n = 33; L554P: 9.07 ± 1.14 ms, n = 29).
To evaluate the effect of L554P mutation on repetitive firing, we
injected neurons with 500-ms current stimuli from 25 to 500 pA in
25-pA increments. Fig. 3A shows the responses of representative
DRG neurons that expressedWT and L554P channels respectively,
to 500-ms steps at 1×, 2×, and 3× current threshold for the re-
spective neuron. DRG neurons expressing L554P fired significantly
more action potentials over a range of stimulation levels (Fig. 3B).
L554P mutation also produced an increase in the proportion
of spontaneously firing DRG neurons (Fig. 3E). Only ∼11% (4
of 37 cells) of DRG neurons expressing WT channels displayed
spontaneous firing. In contrast, ∼34% of DRG neurons expressing
L554P channels displayed spontaneous firing (15 of 44 cells),
significantly more than for WT (P < 0.05). Fig. 3E shows an
example of sustained spontaneous firing from a representative
DRG neuron expressing L554P mutant channels.
A1304T.Current densities (WT: 776 ± 84 pA/pF, n = 18; A1304T:
809 ± 88 pA/pF, n = 19) and persistent currents (WT: 11.1 ±
1.0%, n = 11; A1304T: 9.3 ± 0.6%, n = 13; P > 0.05) in neurons




Activation Steady-state fast inactivation Slow inactivation
V1/2,act k n V1/2,fast k A% n V1/2,slow k A% n
WT 59.1 ± 0.7 −9.8 ± 1.4 −7.47 ± 0.32 27 −35.3 ± 1.2 7.07 ± 0.28 6.69 ± 0.56 27 −49.6 ± 1.1 9.64 ± 0.47 4.25 ± 0.84 10
L554P 60.2 ± 0.6 −11.6 ± 1.6 −6.95 ± 0.37 25 −33.6 ± 1.0 6.61 ± 0.30 6.80 ± 0.96 24 −49.7 ± 1.4 9.62 ± 0.40 3.06 ± 0.67 12
Fig. 3. L554P mutation increases the excitability of small DRG neurons. (A) Response of cells expressing WT (Upper) and L554P (Lower) channels, respectively,
to 500-ms depolarizing current steps at 1×, 2×, and 3× (left, center, and right traces, respectively) current threshold for action potential generation. (B)
Comparison of responses (number of impulses evoked by 500-ms stimulus) in DRG neurons expressing WT (n = 33) and L554P channels (n = 29) across a range
of step current injections from 25 to 500 pA (*P < 0.05). (C) Resting membrane potential (RMP) of neurons expressing WT (−50.1 ± 1.3 mV; n = 33) and L554P
(−49.6 ± 1.4 mV; n = 29) was not significantly different. (D) Current threshold was significantly reduced after expression of L554P (80 ± 14 pA; n = 29),
compared with WT (141 ± 20 pA; n = 33; P < 0.05). (E) Representative recording showing spontaneous firing (30 s) of DRG neuron expressing L554P mutant
channels. Trace was recorded for 30 s without current injection. (Inset) Comparison of portions of WT and L554P neurons that produce spontaneous firing.
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expressing WT and A1304T channels were not significantly dif-
ferent. The half-voltage for activation (V1/2,act) for A1304T was
hyperpolarized by nearly 6 mV compared with WT (A1304T:
−23.0 ± 1.7 mV, n = 13; WT: −17.2 ± 2.2 mV, n = 11) (Fig. 4B,
Table 2). A1304T had no significant effect on steady-state fast
inactivation, or slow inactivation (Table 2).
The amplitude of the response to slow ramp stimuli was not
significantly different for A1304T compared with WT channels
(WT: 27.0 ± 3.5%, n = 11; A1304T: 26.6 ± 2.6%, n = 12; P >
0.05). However, the potential of peak ramp current (VRamp) was
hyperpolarized by 6 mV for A1304T (WT: −22.5 ± 1.9 mV, n =
11; A1304T: −28.5 ± 1.1 mV, n = 12) (Fig. 4 C and D).
Current-clamp recording showed that resting potential was
significantly depolarized by 5 mV (P < 0.01) in DRG neurons
expressing A1304T (−46.3 ± 1.3 mV; n = 35) compared with WT
(−51.3 ± 1.2 mV; n = 34) (Fig. 5C). Input resistance was not sig-
nificantly different in DRG neurons expressing WT (697 ± 74 MΩ;
n = 34) or A1304T mutant channels (543 ± 55 MΩ; n = 35).
Current threshold was significantly reduced after expression of
A1304T (161± 21 pA; n= 35), compared withWT channels (270±
32 pA; n = 34; P < 0.01) (Fig. 5D). Voltage threshold of DRG
neurons expressing A1304T (−29.2 ± 1.5 mV; n = 35) or WT
channels (−29.7 ± 1.2 mV; n = 34) was not significantly different.
There was no significant difference in action potential amplitude
(WT: 103.0 ± 3.9 mV, n = 34; A1304T: 105.5 ± 2.6 mV, n = 35), or
half-width (WT: 5.2± 0.4ms, n= 34; A1304T: 5.6± 0.6ms, n= 35).
DRG neurons expressing A1304T fired significantly more ac-
tion potentials than neurons expressing WT channels over a
range of graded stimulation levels (Fig. 5 A and B).
Discussion
Three sodium channels, Nav1.7, Nav1.8, and Nav1.9, are prefer-
entially expressed in peripheral neurons. Nav1.7 has been
genetically linked to human pain (14, 15), whereas a role for
Nav1.8 and Nav1.9 in pain transmission is supported by animal
studies (14). A crucial role for Nav1.8 in pain signaling has been
supported by several lines of evidence. First, Nav1.8 carries most
of the sodium current underlying the depolarizing phase of ac-
tion potential in DRG neurons (7, 8). Second, Nav1.8 is crucial
for full manifestation of functional effects of Nav1.7 mutations
(16). Third, knockout of Nav1.8 or ablation of Nav1.8-positive
neurons impair thermal hyperalgesia following inflammation (10,
17) and cold-induced pain (18). However, a direct link of Nav1.8
and human pain has not been previously reported. Here, we
report mutations in SCN10A, the gene that encodes Nav1.8, from
patients with painful peripheral neuropathies.
We found gain-of-function changes in Nav1.8 in two of three
mutations studied by voltage and current clamp, based on pre-
dictive algorithms that focused assessment on conserved residues
in transmembrane segments, or in functional sequence motifs
that had a high likelihood of regulating Nav1.8 gating or current
density. A third mutation found in two patients (C1523Y) did not
display gain-of-function changes by voltage clamp. Depending on
whether the additional four mutations identified in 4 patients from
our cohort of 104 patients produced gain-of-function changes, at
least 3 patients and at most 7 patients from this cohort of 104 with
predominantly SFN carry gain-of-function mutations of Nav1.8.
In adults, Nav1.8 is specifically expressed within peripheral
sensory (DRG) neurons (9, 11). Nav1.8 recovers rapidly from
inactivation (19) and contributes the majority of the inward
current responsible for the action potential upstroke during re-
petitive firing of DRG neurons (7, 8). Nav1.8 mutations produced
gain-of-function changes at the channel level (enhanced ramp
responses and repriming for L554P; enhanced activation for
A1304T), and increased excitability of small DRG neurons,
which include nociceptors. Interestingly, the A1304T mutation
hyperpolarized ramp response, by 6 mV, and depolarized resting
potential to a similar degree, by 5 mV.
The mechanisms by which these mutations alter channel gat-
ing are not understood. It is possible that L554P enhances ramp
currents or repriming as a result of a substitution of a structurally
rigid residue, proline, instead of the more flexible residue, leucine,
in a L1 proline-rich motif. The A1304T mutation substitutes a
highly conserved residue within the DIII S5 membrane-spanning
segment with a larger polar residue. Although S5 segments have
not been directly implicated in activation, mutations in DIII/S5
of Nav1.5 (20), Nav1.1 (21, 22), and Nav1.7 (23, 24) have been
linked to channelopathies, with the latter hyperpolarizing acti-
vation in a manner similar to A1304T.
The patients carrying these Nav1.8 mutations displayed distal
neuropathic pain. The L554P mutation was carried by two family
members with painful neuropathy. The pattern of segregation,
together with our functional profiling, suggests a link to painful
neuropathy. The A1304T mutation was observed in a single case.
Nav1.7 and Nav1.8 function in tandem, with Nav1.7 amplifying small
depolarizations to bring the cell to threshold, and Nav1.8 pro-
ducing most of the inward current underlying the action poten-
tial upstroke during repetitive firing (7, 8, 12, 16). However, the
Nav1.8 mutations we describe were identified in patients negative
for mutations in SCN9A, the gene encoding Nav1.7. Definitive
linkage of these Nav1.8 mutations to peripheral neuropathy
would be further supported by the characterization of larger
families, or development of an in vivo animal model. None-
theless, our functional characterizations strongly suggest that
these Nav1.8 mutations contribute to the pathophysiology of
painful neuropathies.
After expression of the mutant channels within DRG neurons,
where Nav1.8 is normally expressed (25, 26), we found at the
channel level, by voltage clamp, enhancement of the response to
depolarization, a proexcitatory effect. By current clamp, we found
that the mutations reduce current threshold and increase firing
frequency in response to suprathreshold stimuli (L554P, A1304T),
depolarize resting potential (A1304), and induce spontaneous
firing of small DRG neurons (L554P), which include nociceptors.
Fig. 4. A1304Tmutation alters hNav1.8 channel properties. (A) Representative
hNav1.8 WT (black) and A1304T (red) currents recorded from DRG neurons. (B)
Activation for A1304T channels was hyperpolarized by ∼6 mV compared with
WT, whereas steady-state fast inactivation of WT and A1304T were not signif-
icantly different. (C) Averaged ramp currents (normalized to maximal transient
peak current) produced by WT Nav1.8 (black; n = 11) and A1304T (red; n = 12)
channels. SEM is indicated by error bars. Voltage dependence of ramp currents
for A1304T was hyperpolarized by 6 mV compared with WT. (D) Mean nor-
malized voltage of peak ramp current for A1304T channels (−28.5 ± 1.1 mV;
n = 12; *P < 0.05) was significantly different from that for WT channels
(−22.5 ± 1.9 mV; n = 11). Data are presented as means ± SEM. *P < 0.05.








The first three changes would be expected to lower threshold for,
or increase intensity of, evoked pain, whereas the latter change
would be expected to contribute to spontaneous pain. Whether
these mutations contribute to axonal degeneration has not been
established. Nav1.8 is abundantly expressed in nociceptive DRG
neurons and their peripheral axons, together with sodium
channels Nav1.6, Nav1.7, and Nav1.9 and the NCX2 Na/Ca ex-
changer (3, 27). Fine-caliber distal axons are especially sensitive
to small changes in sodium channel activity due to high input
resistance, short electrotonic and diffusional length constant, and
high surface-to-volume ratio (28, 29). Persistent sodium current
in myelinated CNS and PNS axons can trigger injurious, Ca2+-
importing reverse Na/Ca exchange (30, 31). I228M Nav1.7 mu-
tant channels, found in a patient with painful neuropathy, reduce
the length of DRG neurites in vitro, whereas blockade of sodium
channels, and of reverse Na/Ca exchange, are protective of axons
expressing mutant, but not wild-type channels, suggesting that
activity of mutant channels and reverse Na/Ca exchange contribute
to axonal injury in this model (32). Whether mutant Nav1.8
channels contribute to axonal injury remains to be established.
In summary, our results demonstrate mutations in Nav1.8, a so-
dium channel specifically expressed in DRG neurons and peripheral
nerve axons, in human subjects with painful neuropathy. Gain-
of-function changes caused by these mutations increase the ex-
citability of DRG neurons. These observations suggest that Nav1.8
mutations contribute to pain in some peripheral neuropathies.
Materials and Methods
Clinical Description. Human studies were approved by Institutional Review
Boards of “Carlo Besta” Neurological Institute and Maastricht University
Medical Center. All aspects of the study were explained, and written in-
formed consent was obtained before study initiation. The two institutes
combined to enroll patients with predominantly idiopathic painful pre-
dominantly SFN [n = 104 (n = 64 from Maastricht; n = 40 from Milan)], all
negative for mutations in SCN9A. All patients were profiled clinically and
intraepidermal nerve fiber density (IENFD) assessed (4, 33) in a standardized
fashion. Laboratory screening was performed to evaluate for diabetes
mellitus, impaired glucose tolerance, hyperlipidemia, liver, kidney, or




Activation Steady-state fast inactivation Slow inactivation
V1/2,act k n V1/2,fast k A% n V1/2,slow k A% n
WT 62.6 ± 2.0 −17.2 ± 2.2 −5.7 ± 0.6 11 −37.2 ± 2.2 5.7 ± 0.3 5.1 ± 0.7 13 −52.1 ± 1.5 8.1 ± 0.6 7.2 ± 1.9 13
A1304T 58.0 ± 2.1 −23.0 ± 1.7* −4.1 ± 0.4* 13 −37.1 ± 1.0 5.3 ± 0.2 4.5 ± 0.8 14 −52.8 ± 1.4 7.4 ± 0.4 3.3 ± 0.9 12
*P < 0.05.
Fig. 5. A1304T increases the excitability of small DRG neurons. (A) Response of cells expressing WT (Upper) and A1304T (Lower) channels, respectively, to
500-ms depolarizing current steps that are 1×, 2×, and 3× (left, center, and right traces, respectively) of current threshold for action potential generation. (B)
Comparison of responses (number of impulses evoked by a 500-ms stimulus) in DRG neurons expressing WT (n = 34) and A1304T channels (n = 35) across
a range of step current injections from 25 to 500 pA; *P < 0.05. (C) Resting membrane potential for A1304T channels was depolarized by 5 mV compared with
WT (WT: −51.3 ± 1.2 mV, n = 34; A1304T: −46.3 ± 1.3 mV, n = 35; **P < 0.01). (D) Current threshold to 200-ms stimuli was reduced in DRG neurons expressing
A1304T (161 ± 21 pA; n = 35) compared with WT channels (270 ± 32 pA; n = 34; **P < 0.01).
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thyroid dysfunction, malignancy, monoclonal gammopathy, connective
tissue disorders, sarcoidosis, amyloidosis, Fabry’s disease (α-galactosidase,
in females combined with GLA-gene sequencing), celiac disease, HIV, alcohol
abuse, hemochromatosis, antiphospholipid syndrome, and B6 intoxication.
Detailed methods are available in SI Materials and Methods.
IENF Quantification. Skin biopsies from the distal leg (10 cm above the lateral
malleolus), obtainedwith a 3-mmpunch after topical anesthesiawith lidocaine,
were fixed [2% (wt/vol) paraformaldehyde–lysine–sodium periodate, 4 °C
overnight] and cryoprotected (4, 34). Immunostaining was performed on serial
sections using polyclonal anti-protein gene product 9.5 antibodies (Ultraclone),
and IENF density (IENF per millimeter) determined and compared with sex-
and age-adjusted normative values (4) using bright-field microscopy applying
established counting rules (34). Intraepidermal nerves that cross or originate at
the dermal–epidermal junction are counted, and secondary branches and
fragments are not counted. At least three sections were analyzed. IENFD is
reported as the mean IENF of these three sections per millimeter (4, 33).
SCN10A Exon Screening. Genomic DNA was extracted from peripheral blood
samples (35). Mutation screening in all 27 exons that constitute SCN10A was
based on National Center for Biotechnology Information’s reference sequences
(genomic, NG_031891.1; coding, CCDS33736.1). Exons were amplified using 200
ng of genomic DNA template by PCR with primers complementary to flanking
intronic sequences as detailed in SI Materials and Methods. DNA control panels
[Milan: 325 controls; Maastricht: 600 controls (100 from ethnically matched
Dutch; 500 from the twin research KCL)] were screened for all mutations.
Primary Sensory Neuron Isolation and Transfection. The WT construct (pcDNA5-
SCN10A) that encodes human Nav1.8 protein was purchased from Genionics.
The L554P or A1304T mutation was introduced into the construct using
QuikChange II XL site-directed mutagenesis (Stratagene).
AnimalstudieswereapprovedbyYaleUniversityandVeteransAdministration
West HavenHospital Animal Use Committees. For voltage-clamp recording, DRG
neurons were isolated from homozygous Nav1.8-cre mice (4–8 wk of age) that
lack endogenous Nav1.8 and transfected by electroporation (36). Filtered DRG
cell suspension was divided into two tubes, sequentially transfected with WT or
mutant Nav1.8 constructs (2 μg of hNav1.8WT or mutant construct plus 0.2 μg of
EGFP) using Nucleofector IIS (Lonza) and Amaxa SCN Nucleofector (VSPI-1003)
(36). Transfected neurons were seeded onto poly-D-lysine/laminin-coated cov-
erslips (BD) and incubated at 37 °C in a 95% air/5% (vol/vol) CO2 incubator. For
current-clamp recordings, DRG from 4- to 8-wk-old Sprague Dawley rats were
harvested, dissociated (37), and transfected as described above. Transfected cell
suspension were diluted in medium supplemented with NGF (50 ng/mL) and
glial cell line-derived neurotrophic factor (50 ng/mL), plated on 12-mm circular
coverslips coated with laminin and poly-ornithine, and incubated at 37 °C in
95% air/5% (vol/vol) CO2 incubator.
Electrophysiology. Voltage-clamp recordings were obtained at 22 ± 1 °C, 36–
54 h after transfection from small DRG neurons (surface area, 250–490 μm2)
with robust green fluorescence (38) and were used to assess activation,
steady-state inactivation, recovery from inactivation, slow inactivation,
and the responses to slow ramp (0.2 mV/ms) depolarizations. Current-clamp
recordings were obtained 40–48 h after transfection. Resting potential,
current threshold, voltage threshold, and response to graded suprathreshold
depolarizations were assessed as previously described (2, 37, 38) and in SI
Materials and Methods.
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